EP2502928


Ref: Examiner(s) Comments in the Examination Report Dated: 27.07.2015 on TKDL Submission Dated: 18.01.2013 in the context of Patent Application No. 10831394.1 (EP2502928) at EPO


1. Third Party Observations under article 115 of EPC

TKDL third party submission under Article 115 EPC brought to the notice of examination division the prior art references on the use of Egg-yolk for the treatment of Chloasma / Melasma / Melanoderma, Freckle, Skin Marks of face, Mothers mark/Naevus and as Nutritive, Cardio-tonic, Brain tonic and General tonic from the books – Muheet-e-Azam, Vol. I by Mohammad Azam Khan (Unani, Exhibit 1, 3 & 4) and Khazaain-al-Advia, Vol. I by Mohammad Najmul Ghani Khan (Unani, Exhibit 2).

2. Relevant Extract of EPO Examination report

EPO Patent Examiner(s) took cognizance of TKDL references. Extract of examination report at para 1 & 3 are reproduced below.

“1 Prior art

D1 “Zardi-eBaiz Neem Brist”,
      TKDL,, 1 January 1896 (1896-01-01), XP003029296

D2 “Nuskha Bara-e-Jhaeen Was Kaiaf”,
     TKDL,, 1 January 1911 (1911-01-01), XP003029297,

D3 “Tila Baiza Biryan”,
      TKDL,, 1 January 1896 (1896-01-01), XP003029298,

D4 Matbookh Zardi-e- Baiz”,
     `TKDL,, 1 January 1896 (1896-01-01), XP003029299,

D2 discloses a method for manufacturing a pharmaceutical composition (against chloasma, melasma, melanoderma, naevus, freckle) and for manufacturing a cosmetic composition (applied on face), wherein egg yolk (i.e. a mixture including the purified egg-yolk phospholipid composition obtained by the method according to any one of claims 1-7) are emulsified (“churned and mixed well”).

D3 and D4 also disclose such methods for manufacturing a pharmaceutical composition, a cosmetic composition and a food composition.”

Full examination report can be referred at EP2502928-II.pdf

3. Current status/ Outcomes of Third Party Observations & Examination Report.

As the outcome of TKDL third party and other documents cited in examination report, the examination is under process.